Where is TransMedics headquartered?

TransMedics is located in Andover, MA.

Who invested in TransMedics?

TransMedics has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for TransMedics?

TransMedics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

transmedics.com

TransMedics

TransMedics is a Massachusetts-based medical device firm that develops and commercializes portable warm blood perfusion systems for living organ transplants.

Business Model:

Revenue: $71.8M

Employees: 51-200

Geographic Data

Address: 200 Minuteman Road

City: Andover

State: MA

Zip: 01810

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$2M

Raised Total:

$261M

Social

Facebook

Twitter

Crunchbase

Metrics

4,661,787Website Global Rank

2,103Website Monthly Traffic

Twitter Followers

Description

TransMedics is a Massachusetts-based medical device firm that develops and commercializes portable warm blood perfusion systems for living organ transplants.

Contact Phone:
+19785520900

Contact Email:

IPO Details

TransMedics went public on 5/1/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/1/2019

IPO Valuation:
$324M

Ticker Symbol:
TMDX

IPO Price:
$16/share

Amount Raised:
$90M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2010	Series E		$0	Foundation Capital Kleiner Perkins Sherbrooke Capital Tudor Investments 3i Group Alta Partners CB Health Ventures Excel Venture Management Flagship Pioneering POSCO BioVentures Sagamore Bioventures VantagePoint Capital Partners Foundation Capital Kleiner Perkins Sherbrooke Capital Tudor Investments 3i Group Alta Partners CB Health Ventures Excel Venture Management Flagship Pioneering POSCO BioVentures Sagamore Bioventures VantagePoint Capital Partners
7/2009	Debt Financing		$2.5M
9/2000	Series A		$0	Alta Partners Chase Capital Partners MedEquity Investors Sofinov Societe Financiere D&s;Innovation Alta Partners Chase Capital Partners MedEquity Investors Sofinov Societe Financiere D&s;Innovation
6/2015	Venture Round		$20M
4/2020	Post-IPO Debt	1	$2.2M	OrbiMed OrbiMed
9/2015	Venture Round		$500k
5/2016	Equity		$63.7M	Flagship Ventures Abrams Capital InBio Ventures BioStar Ventures Lung Biotechnology PBC Kleiner Perkins Caufield Byers
8/2011	Venture Round		$6M
9/2022	Post-IPO Debt		$60M	CIBC Innovation Banking
11/2009	Debt Financing		$3.6M
11/2012	Venture Round	4	$36M	Abrams Capital Flagship Pioneering Hercules Capital Kleiner Perkins Abrams Capital
8/2022	Post-IPO Equity		$130M
9/2022	Post-IPO Debt	1	$60M	CIBC Innovation Banking CIBC Innovation Banking
7/2016	Private Equity Round		$0	Fayerweather Fund Abrams Capital BioStar Capital Kleiner Perkins Lung Biotechnology Flagship Pioneering Inbio Ventures Pharmstandard Fayerweather Fund Pharmstandard Fayerweather Fund Abrams Capital BioStar Capital Kleiner Perkins Lung Biotechnology Flagship Pioneering Inbio Ventures Pharmstandard Fayerweather Fund Pharmstandard
4/2007	Series D		$0	Sherbrooke Capital 3i Group Alta Partners CB Health Ventures Flagship Pioneering POSCO BioVentures Sagamore Bioventures Tudor Investments VantagePoint Capital Partners Sherbrooke Capital 3i Group Alta Partners CB Health Ventures Flagship Pioneering POSCO BioVentures Sagamore Bioventures Tudor Investments VantagePoint Capital Partners
5/2016	Series F		$0	Fayerweather Fund Fayerweather Fund Inbio Ventures Abrams Capital BioStar Capital Flagship Pioneering Kleiner Perkins Lung Biotechnology Millhouse Fayerweather Fund Fayerweather Fund Inbio Ventures Abrams Capital BioStar Capital Flagship Pioneering Kleiner Perkins Lung Biotechnology Millhouse
1/2004	Series B	8	$27.6M	Sherbrooke Capital POSCO BioVentures Novel Bioventures Flagship Pioneering CDP Capital Technology Ventures CB Health Ventures Alta Partners 3i Group Sherbrooke Capital POSCO BioVentures Novel Bioventures Flagship Pioneering CDP Capital Technology Ventures CB Health Ventures Alta Partners 3i Group
3/2006	Series C		$0	Sherbrooke Capital 3i Group Alta Partners CB Health Ventures Flagship Pioneering POSCO BioVentures Sagamore Bioventures VantagePoint Capital Partners Sherbrooke Capital 3i Group Alta Partners CB Health Ventures Flagship Pioneering POSCO BioVentures Sagamore Bioventures VantagePoint Capital Partners
5/2019	IPO		$91.9M
7/2016	Private Equity Round	8	$12.5M	Fayerweather Fund Abrams Capital BioStar Capital Kleiner Perkins Lung Biotechnology Flagship Pioneering Inbio Ventures Pharmstandard Fayerweather Fund Pharmstandard Fayerweather Fund Abrams Capital BioStar Capital Kleiner Perkins Lung Biotechnology Flagship Pioneering Inbio Ventures Pharmstandard Fayerweather Fund Pharmstandard
5/2016	Series F	8	$51.2M	Fayerweather Fund Fayerweather Fund Inbio Ventures Fayerweather Fund Fayerweather Fund Inbio Ventures
3/2010	Series E	12	$36M	Foundation Capital Kleiner Perkins Foundation Capital Kleiner Perkins

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details